methods of treating or inhibiting mucositis, radiation cystitis in an individual, and treating at least one symptom of an individual's exposure to a cytotoxic agent or radiation, and, pharmaceutical composition
The present invention provides a method of treating or inhibiting mucositis or radiation cystitis using an ERbeta selective ligand. The present invention also provides compositions, including pharmaceutical compositions, containing the ERbeta selective ligand and a traditional medicament for mucositis or radiation cystitis.